CD8A and cancer: The data suggest that LNT may enhance cancer immunotherapy via modulating neutrophils, while all of increased CD8+ T cells, increased neutrophils and reduced TAMs may contribute to tumor growth inhibition induced by the combination of LNT treatments and DLL1 overexpression.